Evidence mapPaperPMID 41185023Full record

ArticleFluids and barriers of the CNS2025

Metformin's protection against blood-brain barrier disruption and neuronal dysfunction under oxygen-glucose deprivation and tobacco smoke and e-vape chemical exposure.

Khondker Ayesha Akter, Sejal Sharma, Sejal Rajesh Jadhav, Yong Zhang, Thomas J Abbruscato

Abstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Khondker Ayesha AkterDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, 79106, USA.
Sejal SharmaDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, 79106, USA.
Sejal Rajesh JadhavDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, 79106, USA.
Yong ZhangDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, 79106, USA.
Thomas J AbbruscatoDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, 79106, USA. thomas.abbruscato@ttuhsc.edu.

Funding

NIH HHS R01NS117906 to TJA
6 · The paper itself

Abstract

backgroundAccording to our previous findings, the integrity of the blood-brain barrier (BBB) is affected by tobacco smoke (TSe) and electronic cigarette (ECe) exposure, and metformin (MF) can counter these detrimental effects. It is unknown, therefore, if MF protects against neuronal dysfunction after BBB damage caused by either TSe or ECe alone or combined exposure (TSe and ECe) in stroke cases. Additionally, MF's ability to enter the ischemic brain during ischemic stroke is unknown. The purpose of this effort is to address these questions.

methodsA well-established bEnd3/astrocyte co-culture in vitro BBB model was utilized to conduct permeability studies. Normoxia and hypoxia using oxygen-glucose deprivation (OGD) conditions were used to mimic the in vitro stroke conditions. Western blot (WB) and immunofluorescence analysis were performed for relevant molecular targets. Additionally, mitochondrial dysfunction was assessed using Seahorse Mito-stress analysis using primary neurons. Also, tMCAO was performed in C57BL/6 J mice to create ischemic injury. To quantify MF in the mouse brain, a highly sensitive LC-MS/MS technique was used.

resultsAccording to our findings, a decrease in transendothelial electric resistance (TEER) values and increased permeability coefficient (PC) for sodium fluorescein were observed in the OGD/R condition alone or when combined with TSe, ECe, or mixed exposure compared to the control group. MF pretreatment, however, protected the BBB from losing barrier properties by increasing the TEER and decreasing PC values. Altered expression of tight junction (TJ) proteins was observed following TSe and ECe exposure paired with OGD compared to the control and OGD alone. However, MF was capable of offsetting the majority of these adverse effects by differentially upregulating ZO-1, occludin, and claudin-5 expression. Altered neuronal mitochondrial dynamics and decreased OCR were observed after OGD alone or in combination with TSe or ECe, however, MF pretreatment significantly increased several indices of mitochondrial functions, especially basal respiration, ATP production, and non-mitochondrial O

conclusionOur findings demonstrate that MF pretreatment could be an effective countermeasure following OGD exposure in conjunction with TSe and ECe exposure, which is often linked to the deterioration of the BBB and possibly mitochondrial function.

Indexed as

Blood-Brain BarrierElectronic Nicotine Delivery SystemsMetforminNeuronsNeuroprotective AgentsAnimalsAstrocytesCell LineCoculture TechniquesGlucoseMaleMiceMice, Inbred C57BLGlucoseMetforminNeuroprotective AgentsBBBElectronic cigaretteMitochondrial dysfunctionStrokeTobacco smoke

Identifiers

PMID41185023
PMCPMC12581476

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.